Abstracts

HIV SEROLOGY FOLLOWING TREATMENT INTERRUPTION IN VERY EARLY TREATED PEOPLE

Antiretroviral therapy (ART) initiated during acute HIV infection (AHI) may result in HIV seronegativity. Little is known about the serologic profile following ART treatment interruption (ATI) in such individuals. Knowledge gained could inform recommendations for HIV diagnostic testing following pre- and post-exposure prophylaxis. Participants initiating ART and virally suppressed during Fiebig (F)-I or F-III stage…

REEVALUATING SIGNALS OF VIRAL REPLICATION & EVOLUTION IN LYMPHOID TISSUE DURING ART

Mechanisms for long-term HIV persistence despite antiretroviral therapy (ART) continue to be debated. Many studies have offered evidence that ART halts self-sustaining viral replication in most patients and that long-lived resting memory CD4+ T-cells support a stable latent reservoir (LR) of integrated virus. However, Lorenzo-Redondo et al. [Nature, 2016] deep-sequenced lymph node and blood samples…

MONITORING THE IMPACT OF ART MODIFICATION WITH LONGITUDINAL FDG-PET IN SIV-MODEL

The aim of this study was to assess immune activation in various organs by longitudinally measuring changes in glucose metabolism associated with initiation and interruption of combination antiretroviral therapy (cART) in SIV-infected macaques. We also assessed the associations of various markers of disease activity with tissue metabolic activity. Whole body 18F-Fluorodeoxyglucose (FDG) PET-imaging was obtained…

SPREAD OF HIV-DNA IN CD4+ T-CELL SUBSETS DEPENDS ON ART INITIATION TIMING

Life-long resting CD4+ T-cells are the major long-lasting reservoir in HIV-infected individuals. The aim of our study is to analyze the dynamics of archived HIV-DNA in CD4+ T-cells subsets in individuals starting successful dolutegravir-based regimen over 48 weeks. Participants from the prospective longitudinal DRONE study (NCT02557997) including: treatment-naïve individuals who initiated treatment with a dolutegravir-based…

ADJUNCTIVE SERTRALINE IN HIV-ASSOCIATED CRYPTOCOCCAL MENINGITIS

Identifying new antifungals effective for cryptococcal meningitis (CM) remains a priority given the high costs, toxicity, and limited availability of current first line therapy. Sertraline has previously demonstrated in vitro and in vivo activity against Cryptococcus. We evaluated the efficacy of adjunctive sertraline for cryptococcal meningitis in a double-blind, randomized, placebo-controlled clinical trial. We assessed…